UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

Example RegulatedAuthorization: Orimox-50mcg-Suspension-SE-IS-RA

Generated Narrative: RegulatedAuthorization Orimox-50mcg-Suspension-SE-IS-RA

identifier: http://ema.europa.eu/fhir/marketingAuthorizationNumber/55400

subject: MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100002342-00055400,http://ema.europa.eu/fhir/eurdId#2085; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Nasal spray, suspension; indication = Orimox nässpray är avsett för vuxna och äldre för behandling av symtom vid säsongsbunden allergisk eller perenn rinit.; legalStatusOfSupply = Medicinal product not subject to medical prescription; classification = R01AD09

type: Marketing Authorisation

region: Kingdom of Sweden

status: Valid

statusDate: 2017-06-16

holder: Organization Orifarm Generics A/S

Cases

-TypeDate[x]
*First Authorisation2017-06-16